• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含具有醇、羧酸和乙酸酯取代基的乙二胺衍生配体的铂(II)和铂(IV)配合物的合成及抗肿瘤活性。[PtL4CL2].H20的晶体和分子结构,其中L4为乙二胺-N,N'-二乙酸酯。

Synthesis and antitumour activity of platinum(II) and platinum(IV) complexes containing ethylenediamine-derived ligands having alcohol, carboxylic acid and acetate substituents. Crystal and molecular structure of [PtL4CL2].H20 where L4 is ethylenediamine-N,N'-diacetate.

作者信息

Jolley J N, Yanovsky A I, Kelland L R, Nolan K B

机构信息

Department of Chemistry, Royal College of Surgeons in Ireland, St. Stephen's Green, Dublin.

出版信息

J Inorg Biochem. 2001 Jan 15;83(2-3):91-100. doi: 10.1016/s0162-0134(00)00190-2.

DOI:10.1016/s0162-0134(00)00190-2
PMID:11237267
Abstract

Several cisplatin analogues of ethylenediamine-derived ligands containing alcohol, carboxylic acid and acetate substituents have been prepared and characterised. Oxidation of some of these square planar platinum(II) complexes using aqueous hydrogen peroxide gave octahedral platinum(IV) complexes, containing trans hydroxo ligands. Acetylation of the hydroxo ligands was achieved by reaction with acetic anhydride, giving complexes which are analogues of the antitumour drug, JM-216. Oxidation of the complex [Pt(H2L4)Cl2], where H2L4 is ethylenediamine-N,N'-diacetic acid, with H2O2 gave the platinum(IV) complex [PtL4Cl2].H2O in which L4 is tetradentate as shown by a crystal and molecular structure. This complex was previously reported to be [Pt(HL4)(OH)Cl2] in which HL4 is tridentate. Several of the complexes were tested for antitumour activity against five human ovarian carcinoma cell lines. IC50 values range from 4.0 microM for cis,trans-PtCl2(OH)2(NH2CH2CH2NHCH2CH2OH) against the CH1 cell line to >25 microM indicating moderate to low activity relative to other platinum complexes.

摘要

已经制备并表征了几种含有醇、羧酸和乙酸酯取代基的乙二胺衍生配体的顺铂类似物。使用过氧化氢水溶液氧化其中一些平面正方形铂(II)配合物,得到了含有反式羟基配体的八面体铂(IV)配合物。通过与乙酸酐反应实现羟基配体的乙酰化,得到了与抗肿瘤药物JM-216类似的配合物。用H2O2氧化配合物[Pt(H2L4)Cl2](其中H2L4是乙二胺-N,N'-二乙酸),得到铂(IV)配合物[PtL4Cl2].H2O,晶体和分子结构表明L4是四齿的。该配合物先前报道为[Pt(HL4)(OH)Cl2],其中HL4是三齿的。测试了几种配合物对五种人卵巢癌细胞系的抗肿瘤活性。IC50值范围从顺式、反式-PtCl2(OH)2(NH2CH2CH2NHCH2CH2OH)对CH1细胞系的4.0 microM到>25 microM,表明相对于其他铂配合物活性为中度至低度。

相似文献

1
Synthesis and antitumour activity of platinum(II) and platinum(IV) complexes containing ethylenediamine-derived ligands having alcohol, carboxylic acid and acetate substituents. Crystal and molecular structure of [PtL4CL2].H20 where L4 is ethylenediamine-N,N'-diacetate.含具有醇、羧酸和乙酸酯取代基的乙二胺衍生配体的铂(II)和铂(IV)配合物的合成及抗肿瘤活性。[PtL4CL2].H20的晶体和分子结构,其中L4为乙二胺-N,N'-二乙酸酯。
J Inorg Biochem. 2001 Jan 15;83(2-3):91-100. doi: 10.1016/s0162-0134(00)00190-2.
2
Synthesis and in vitro and in vivo antitumor activity of a series of trans platinum antitumor complexes.一系列反式铂抗肿瘤配合物的合成及其体内外抗肿瘤活性
J Med Chem. 1995 Aug 4;38(16):3016-24. doi: 10.1021/jm00016a004.
3
Synthesis, characterization and antitumor activity of novel octahedral Pt(IV) complexes.新型八面体铂(IV)配合物的合成、表征及抗肿瘤活性
Bioorg Med Chem. 2003 Apr 17;11(8):1669-76. doi: 10.1016/s0968-0896(03)00044-0.
4
Preparation and characterization of platinum(II) and (IV) complexes of 1,3-diaminepropane and 1,4-diaminebutane: circumvention of cisplatin resistance and DNA interstrand cross-link formation in CH1cisR ovarian tumor cells.1,3 - 二氨基丙烷和1,4 - 二氨基丁烷的铂(II)和铂(IV)配合物的制备与表征:克服顺铂耐药性及在CH1cisR卵巢肿瘤细胞中形成DNA链间交联
J Med Chem. 2002 Apr 25;45(9):1835-44. doi: 10.1021/jm010968l.
5
Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.轴向和赤道配体对反式-1R,2R-二氨基环己烷铂(IV)配合物抗肿瘤活性的调节作用。
Anticancer Drug Des. 1994 Apr;9(2):139-51.
6
Synthesis and X-ray crystal structure of trans,cis-[Pt(OAc)2I2(en)]: a novel type of cisplatin analog that can be photolyzed by visible light to DNA-binding and cytotoxic species in vitro.反式,顺式-[Pt(OAc)₂I₂(en)]的合成与X射线晶体结构:一种新型顺铂类似物,可在体外被可见光光解为具有DNA结合能力和细胞毒性的物质。
J Med Chem. 1996 Jun 21;39(13):2499-507. doi: 10.1021/jm9509105.
7
Synthesis, characterization and cytotoxicity of new platinum(IV) axial carboxylate complexes: crystal structure of potential antitumor agent [PtIV(trans-1R,2R-diaminocyclohexane)trans(acetate)2Cl2].新型羧酸根轴向铂(IV)配合物的合成、表征及细胞毒性:潜在抗肿瘤药物[PtIV(反式-1R,2R-二氨基环己烷)反式(乙酸根)2Cl2]的晶体结构
Bioorg Med Chem. 2000 Mar;8(3):515-21. doi: 10.1016/s0968-0896(99)00313-2.
8
Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.铂核碱基和核苷配合物模型及其抗肿瘤活性:[PtIV(反式-1R,2R-二氨基环己烷)反式-(乙酸根)2(9-乙基鸟嘌呤)氯]硝酸盐水合物的X射线晶体结构
J Inorg Biochem. 2005 Mar;99(3):795-804. doi: 10.1016/j.jinorgbio.2004.12.015.
9
Complexes of oxoplatin with rhein and ferulic acid ligands as platinum(iv) prodrugs with high anti-tumor activity.奥沙利铂与大黄酸和阿魏酸的配合物作为具有高抗肿瘤活性的铂(IV)前药。
Dalton Trans. 2020 Feb 7;49(5):1613-1619. doi: 10.1039/c9dt04594e. Epub 2020 Jan 16.
10
In Vitro Anticancer Evaluation of Platinum(II/IV) Complexes with Diisoamyl Ester of (S,S)-ethylenediamine-N,N'-di-2-propanoic Acid.含(S,S)-乙二胺-N,N'-二-2-丙酸二异戊酯的铂(II/IV)配合物的体外抗癌评估
Anticancer Agents Med Chem. 2017;17(8):1136-1143. doi: 10.2174/1871520616666161207155634.

引用本文的文献

1
Chronic effects of platinum(IV) complex and its diamine ligand on rat heart function: comparison with cisplatin.铂(IV)配合物及其二胺配体对大鼠心功能的慢性影响:与顺铂的比较。
Mol Cell Biochem. 2019 Aug;458(1-2):89-98. doi: 10.1007/s11010-019-03533-8. Epub 2019 Apr 15.
2
Oxidative Reactivity and Cytotoxic Properties of a Platinum(II) Complex Prepared by Outer-Sphere Amide Bond Coupling.通过外层酰胺键偶联制备的铂(II)配合物的氧化反应性和细胞毒性特性
Polyhedron. 2013 Jul 13;58:71-78. doi: 10.1016/j.poly.2012.07.097.
3
Synthetic methods for the preparation of platinum anticancer complexes.
铂类抗癌配合物的合成方法。
Chem Rev. 2014 Apr 23;114(8):4470-95. doi: 10.1021/cr4004314. Epub 2013 Nov 27.